Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease

Younossi, 2020, Epidemiology of chronic liver diseases in the USA in the past three decades, Gut, 69, 564, 10.1136/gutjnl-2019-318813 Younossi, 2021, Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States, Clin Gastroenterol Hepatol, 19, 580, 10.1016/j.cgh.2020.05.064 Lee, 2022, Inflammatory and fibrotic mechanisms in NAFLD-Implications for new treatment strategies, J Intern Med, 291, 11, 10.1111/joim.13380 Powell, 2021, Non-alcoholic fatty liver disease, Lancet, 397, 2212, 10.1016/S0140-6736(20)32511-3 Taylor, 2020, Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis, Gastroenterology, 158, 1611, 10.1053/j.gastro.2020.01.043 Dulai, 2017, Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis, Hepatology, 65, 1557, 10.1002/hep.29085 Noureddin, 2022, Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017-2018 transient elastography data and application of machine learning, Hepatol Commun, 6, 1537, 10.1002/hep4.1935 Johnston, 2011, STAT3 signaling: anticancer strategies and challenges, Mol Interv, 11, 18, 10.1124/mi.11.1.4 Carpenter, 2014, STAT3 target genes relevant to human cancers, Cancers, 6, 897, 10.3390/cancers6020897 Wang, 2011, Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target, Int J Biol Sci, 7, 536, 10.7150/ijbs.7.536 Choi, 2018, Expression patterns of STAT3, ERK and estrogen-receptor alpha are associated with development and histologic severity of hepatic steatosis: a retrospective study, Diagn Pathol, 13, 23, 10.1186/s13000-018-0698-8 Su, 2015, Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition, Proc Natl Acad Sci United States America, 112, 7243, 10.1073/pnas.1507499112 Horiguchi, 2007, Liver regeneration is suppressed in alcoholic cirrhosis: correlation with decreased STAT3 activation, Alcohol, 41, 271, 10.1016/j.alcohol.2007.04.008 Yang, 2007, Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma, J Clin Pathol, 60, 642, 10.1136/jcp.2006.036970 Liang, 2018, Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma, OncoTargets Ther, 11, 1203, 10.2147/OTT.S156198 Grohmann, 2018, Obesity drives STAT-1-dependent NASH and STAT-3-dependent HCC, Cell, 175, 1289, 10.1016/j.cell.2018.09.053 Jung, 2017, Multifunctional effects of a small-molecule STAT3 inhibitor on NASH and hepatocellular carcinoma in mice, Clin Cancer Res : official J Am Assoc Cancer Res, 23, 5537, 10.1158/1078-0432.CCR-16-2253 Wang, 2018, The STAT3 inhibitor S3I-201 suppresses fibrogenesis and angiogenesis in liver fibrosis, Lab Invest, 98, 1600, 10.1038/s41374-018-0127-3 Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701 Perkins, 2012, ReadqPCR and NormqPCR: R packages for the reading, quality checking and normalisation of RT-qPCR quantification cycle (Cq) data, BMC Genomics, 13, 296, 10.1186/1471-2164-13-296 MacParland, 2018, Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations, Nat Commun, 9, 4383, 10.1038/s41467-018-06318-7 Han, 2018, Mapping the mouse cell atlas by microwell-seq, Cell, 172, 1091, 10.1016/j.cell.2018.02.001 Hu, 2020, CREBZF as a key regulator of STAT3 pathway in the control of liver regeneration in mice, Hepatology, 71, 1421, 10.1002/hep.30919 He, 2011, NF-kappaB and STAT3 - key players in liver inflammation and cancer, Cel Res, 21, 159, 10.1038/cr.2010.183 Meng, 2012, Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice, Gastroenterology, 143, 765, 10.1053/j.gastro.2012.05.049 Xiang, 2018, The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis, Gut, 67, 1704, 10.1136/gutjnl-2016-313392 Fabregat, 2018, Transforming growth factor-beta-induced cell plasticity in liver fibrosis and hepatocarcinogenesis, Front Oncol, 8, 357, 10.3389/fonc.2018.00357 Xu, 2016, TGF-beta/SMAD pathway and its regulation in hepatic fibrosis, J Histochem Cytochem : official J Histochem Soc, 64, 157, 10.1369/0022155415627681 Henderson, 2006, Galectin-3 regulates myofibroblast activation and hepatic fibrosis, Proc Natl Acad Sci United States America, 103, 5060, 10.1073/pnas.0511167103 Jeftic, 2015, Galectin-3 ablation enhances liver steatosis, but attenuates inflammation and IL-33-dependent fibrosis in obesogenic mouse model of nonalcoholic steatohepatitis, Mol Med, 21, 453, 10.2119/molmed.2014.00178 Xu, 2014, Stat3 signaling activation crosslinking of TGF-beta1 in hepatic stellate cell exacerbates liver injury and fibrosis, Biochim Biophys Acta, 1842, 2237, 10.1016/j.bbadis.2014.07.025 Liu, 2013, Transforming growth factor-beta (TGF-beta)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation, J Biol Chem, 288, 30708, 10.1074/jbc.M113.478685 Tang, 2017, Transforming growth factor-beta (TGF-beta) directly activates the JAK1-STAT3 Axis to induce hepatic fibrosis in coordination with the SMAD pathway, J Biol Chem, 292, 4302, 10.1074/jbc.M116.773085 Cierpka, 2021, Perilipin 5 ameliorates hepatic stellate cell activation via SMAD2/3 and SNAIL signaling pathways and suppresses STAT3 activation, Cells, 10, 2184, 10.3390/cells10092184 Gwag, 2022, Anti-CD47 antibody treatment attenuates liver inflammation and fibrosis in experimental non-alcoholic steatohepatitis models, Liver Int, 42, 829, 10.1111/liv.15182 Ramachandran, 2019, Resolving the fibrotic niche of human liver cirrhosis at single-cell level, Nature, 575, 512, 10.1038/s41586-019-1631-3 Choi, 2019, IL-10-secreting human MSCs generated by TALEN gene editing ameliorate liver fibrosis through enhanced anti-fibrotic activity, Biomater Sci, 7, 1078, 10.1039/C8BM01347K Karl, 2022, Dual roles of B lymphocytes in mouse models of diet-induced nonalcoholic fatty liver disease, Hepatology, 76, 1135, 10.1002/hep.32428 Terkelsen, 2020, Transcriptional dynamics of hepatic sinusoid-associated cells after liver injury, Hepatology, 72, 2119, 10.1002/hep.31215 Ramirez-Pedraza, 2019, Interplay between macrophages and angiogenesis: a double-edged sword in liver disease, Front Immunol, 10, 2882, 10.3389/fimmu.2019.02882 Wan, 2014, Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells, Gastroenterology, 147, 1393, 10.1053/j.gastro.2014.08.039 Chen, 2016, LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression, Nat Commun, 7, 10.1038/ncomms12598 Wang, 2016, Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis, J Hepatol, 64, 1283, 10.1016/j.jhep.2016.01.019 Won, 2015, Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma, Hepatology, 62, 1160, 10.1002/hep.27968 Uthaya Kumar, 2016, TLR4 signaling via NANOG cooperates with STAT3 to activate Twist1 and promote formation of tumor-initiating stem-like cells in livers of mice, Gastroenterology, 150, 707, 10.1053/j.gastro.2015.11.002 Greenbaum, 2011, The role of stem cells in liver repair and fibrosis, Int J Biochem Cel Biol, 43, 222, 10.1016/j.biocel.2009.11.006 Grzelak, 2014, The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury, J Hepatol, 60, 143, 10.1016/j.jhep.2013.08.012 Zhang, 2015, miR-21 inhibition reduces liver fibrosis and prevents tumor development by inducing apoptosis of CD24+ progenitor cells, Cancer Res, 75, 1859, 10.1158/0008-5472.CAN-14-1254 Cunningham, 2021, Liver zonation - revisiting old questions with new technologies, Front Physiol, 12, 10.3389/fphys.2021.732929